Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Myeloproliferative Disorders 2Myelodysplastic Syndromes 2Leukemia, Myelomonocytic, Chronic 2Leukemia, Myeloid, Acute 2Polycystic Ovary Syndrome 1Myelodysplastic-Myeloproliferative Diseases 1Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 1Leukemia, Lymphocytic, Chronic, B-Cell 1Leukemia 1Insulin Resistance 1Inflammation 1Hyperandrogenism 1Congenital Abnormalities 1Anovulation 1Anemia, Refractory, with Excess of Blasts 1

Interventions

Metformin 7Progesterone 6Spironolactone 4drospirenone and ethinyl estradiol combination 3Inositol 3Ethinyl Estradiol 3salicylsalicylic acid 2Sugars 2Folic Acid 2Flutamide 2Estradiol 2Cyproterone Acetate 2maltodextrin 1bicalutamide 1Yoga 1Waist-Hip Ratio 1Waist Circumference 1Ultrasonography 1Topiramate 1Time 1Thioctic Acid 1Sodium Salicylate 1Sex Characteristics 1Physical Examination 1Phlebotomy 1Phenotype 1Ovidrel 1Magnesium 1Lactalbumin 1Inulin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Hyperandrogenism × Sodium Salicylate × Clear all
NCT03229408 2025-06-10

TIN-PCOS-AOD

University of Illinois at Chicago

Phase 2 Completed
60 enrolled 28 charts

Anovulation, Inflammation, Insulin Resistance, Polycystic Ovary Syndrome, Hyperandrogenism

Data powered by HemOnc (CC BY 4.0) Colophon âš¡